Case Study

Incentivizing Pharmaceutical Innovation

A biotech startup has discovered a new molecule that shows promise in treating a rare genetic disease. The research and development process to prove its safety and efficacy will cost hundreds of millions of dollars and take nearly a decade. However, once the chemical structure of the molecule is known, other pharmaceutical companies could synthesize it for a fraction of the cost. The startup's investors are hesitant to provide funding, fearing they will not be able to recoup their massive initial investment.

Based on the principles of addressing market failures, what specific legal mechanism could a government implement to make this investment more attractive to the startup and its investors? Explain how this mechanism addresses the core economic problem described in the scenario.

0

1

Updated 2025-07-29

Contributors are:

Who are from:

Tags

Social Science

Empirical Science

Science

CORE Econ

Economy

Economics

Introduction to Microeconomics Course

The Economy 2.0 Microeconomics @ CORE Econ

Related